Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

46.47
+0.20000.43%
Post-market: 46.470.00000.00%19:14 EDT
Volume:2.19M
Turnover:101.34M
Market Cap:8.82B
PE:-13.14
High:46.76
Open:45.98
Low:45.73
Close:46.27
Loading ...
Jul 02, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities